One-shot Ovarian Stimulation Protocol (One-shot)
Recruiting now · Not applicable
Conditions studied: Infertility, Female
In brief
The current prospective observational pilot study aims to evaluate the endocrine profile of a single-injection protocol (single CFA + daily oral administration of CC).
Key facts
- Study ID
- NCT06635538
- Run by
- Fundación Santiago Dexeus Font
- People needed
- 20
- Starts
- 2024-10-31
- Expected to finish
- 2025-04-01
- Last updated by the study team
- 2025-02-26
Who can join
Age: 18 and older, up to 40. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Age <= 40
- AMH (Anti-Mullerian Hormone) 1.2-3.5 ng/ml or AFC 7-20
- No family history of hereditary or chromosomal diseases
- Body mass index (BMI) 18 to 30 kg/m2
Where it is running
- Dexeus Mujer Sabadell — Sabadell, Barcelona, Spain (enrolling)
- Dexeus Mujer Sant Cugat — Sant Cugat del Vallès, Barcelona, Spain (enrolling)
- Departamento de Ginecología Obstetricia y Reproducción. Hospital Universitari Dexeus — Barcelona, Spain
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.